Repligen Corp. (RGEN)

165.02 -1.34 (-0.81%) USD  |  NASDAQ  |  Dec 24, 11:08
More

Repligen SG&A Expense (TTM): 276.62M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for RGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Enovis Corp. 1.057B
Teleflex, Inc. 974.11M
Globus Medical, Inc. 1.113B
Perspective Therapeutics, Inc. 31.53M
Xtant Medical Holdings, Inc. 74.03M